Delivery Order SPE2DB22D3016-SPE2DB24FAPS1
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,251.85, is for the delivery of Neulasta OnPro 6 mg/0.6 mL kits. This is a firm fixed-price delivery order with a completion date of June 5, 2024. The contract is not set aside for any specific business type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $11,306.08, is for the delivery of Neulasta OnPro 6 mg/0.6 ml kits, a specialty medication used in the treatment of certain medical conditions. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 5, 2025. This award is not associated with a set-aside...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $27,729.49, is for the supply of Neulasta OnPro 6 mg/0.6 ml kits to support federal healthcare programs, particularly military and veterans' healthcare systems. The contract has an ultimate completion date of February 4, 2025. AmerisourceBergen holds a significant Indefinite...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Neulasta OnPro 6 mg/0.6 ml kits. The order, valued at $6,176.80, has a completion date of February 8, 2024. Amerisourcebergen Drug Corp provides pharmaceuticals, medical supplies, and related distribution services to support military treatment programs and facilities under an indefinite delivery...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,831.39, is for the delivery of NEULASTA ONPRO 6 MG/0.6 ML KIT 0.6ML, a specialty medication. This contract does not have a set-aside designation, indicating it was competed openly. AmerisourceBergen is the prime contractor, and the contract has an ultimate completion date of...
- This federal contract award to AmerisourceBergen Drug Corp's Corporate Office Division is for the delivery of Neulasta OnPro 6 mg/0.6 ml kits to support U.S. government medical requirements. The $21,560.76 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA) under an existing Indefinite Delivery Contract (IDC) that has a total potential value of up to $999,999,999 for providing a comprehensive range of pharmaceutical and medical supplies to military treatment programs...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,349.28 firm fixed-price delivery order is for the supply of the drug Neulasta OnPro, a biologic medication used to help prevent infections in cancer patients undergoing chemotherapy. The contract has an ultimate completion date of November 14, 2024 and was awarded on November 13, 2022. It...
- The Defense Logistics Agency awarded a delivery order valued at $2,337.32 to AmerisourceBergen Drug Corp for Neulasta OnPro 6 mg/0.6 mL kits on September 12, 2025, with completion expected by September 15, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award. Performance will be executed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a $1,237.65 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Neulasta OnPro 6 mg/0.6 mL Kit on December 9, 2025, with a completion date of December 10, 2025. This non-set-aside competitive award is a child contract executed under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery will be performed at...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Neulasta, a specialty medication, with a ceiling value of $95,008.32. This is a firm fixed price delivery order contract and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB24FAPS1Delivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,043.64, is for the delivery of Neulasta OnPro 6 mg/0.6 ml kits, a specialty medication used in the treatment of certain medical conditions. The contract is a firm fixed-price delivery order with a completion date of March 12, 2024. This award is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.0k | 3/11/24 |